Company / Net Income
AGIOS PHARMACEUTICALS, INC. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$412.8M
FY2025
5-year range
-$412.8M / $1.6B
FY2021-FY2025
Trend
-161.3%
vs FY2024
Sector context
#194 of 216
Health Care
What the data says
Among 216 Health Care companies, AGIOS PHARMACEUTICALS, INC. is in the bottom 10% for net income. Net Income has fluctuated over the past 10 years, ranging from -$413M in FY2025 to $1.6B in FY2021.
Based on SEC 10-K filings.
-$413M in FY2025.
Declined from -$352M to -$413M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 10% in Health CareTop 90% of 216This company -$412.8M Sector average $454.1M
▼
-190.9% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 161.3% year-over-year.
- Ranks #194 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$412.8M | -161.3% |
| FY2024 | $673.7M | +291.4% |
| FY2023 | -$352.1M | -7.6% |
| FY2022 | -$327.4M | -120.4% |
| FY2021 | $1.6B | +563.8% |
| FY2020 | -$346.0M | +15.9% |
| FY2019 | -$411.5M | -107.3% |
| FY2018 | -$198.5M | +36.9% |
| FY2017 | -$314.7M | -58.5% |
| FY2016 | -$198.5M | -403.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026